Literature DB >> 24037565

Long-term clinical and functional outcome following treatment for Paget-Schroetter syndrome.

J M Taylor1, R J Telford, D C Kinsella, A F Watkinson, J F Thompson.   

Abstract

BACKGROUND: Effort-related thrombosis of the axillosubclavian vein (Paget-Schroetter syndrome, PSS) is uncommon. It tends to affect young, active individuals and yet consensus on management is lacking. The aim here was to analyse late outcomes in a series of patients treated for PSS using a standard protocol.
METHODS: The medical records of patients treated for PSS over 16 years were analysed. Patients were divided into four groups according to their management. Clinical and functional outcomes were analysed regarding residual venous defects after treatment, and Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire scores, respectively.
RESULTS: Some 117 patients (52 men and 65 women, mean age 32 years) were included. Catheter-directed thrombolysis was successful in 42 of 56 treated patients. Thoracic outlet decompression surgery was performed in 95 patients. DASH scores improved significantly in patients treated surgically (P < 0.001 to P = 0·009); early surgery had a better outcome than delayed surgery (P = 0·040). Patients who were managed conservatively showed no improvement (P = 0·116). Where venoplasty was necessary, it was successful in 18 of 25 patients. A short duration of lysis (less than 24 h) increased the risk of rethrombosis (P = 0·020). The method of postoperative anticoagulation had no influence on the rate of rethrombosis.
CONCLUSION: Patients treated surgically for PSS had better functional outcomes than those managed conservatively. Prompt thrombolysis and surgery was superior to delayed management with respect to rethrombosis and functional outcome.
© 2013 British Journal of Surgery Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 24037565     DOI: 10.1002/bjs.9279

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

Review 1.  How We Manage Pediatric Deep Venous Thrombosis.

Authors:  Marisol Betensky; Mark A Bittles; Paul Colombani; Neil A Goldenberg
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

Review 2.  Paget-Schroetter syndrome: treatment of venous thrombosis and outcomes.

Authors:  Patrick Hangge; Lisa Rotellini-Coltvet; Amy R Deipolyi; Hassan Albadawi; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

3.  Paget-Schroetter syndrome complicated by an incidental pulmonary embolism.

Authors:  Jakub Kaczynski; Joseph Sathiananthan
Journal:  BMJ Case Rep       Date:  2017-08-02

4.  Racial and Sex Disparities in Catheter Use and Dialysis Access in the United States Medicare Population.

Authors:  Shipra Arya; Taylor A Melanson; Elizabeth L George; Kara A Rothenberg; Manjula Kurella Tamura; Rachel E Patzer; Jason M Hockenberry
Journal:  J Am Soc Nephrol       Date:  2020-01-15       Impact factor: 10.121

5.  A case of Paget-Schroetter syndrome (PSS) in a young judo tutor: a case report.

Authors:  Ruth Ijaopo; Victor Oguntolu; Dominick DCosta; Andrew Garnham; Simon Hobbs
Journal:  J Med Case Rep       Date:  2016-03-18

Review 6.  Catheter-Based Therapies and Other Management Strategies for Deep Vein Thrombosis and Post-Thrombotic Syndrome.

Authors:  Siddhant Thukral; Suresh Vedantham
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

7.  Paget-Schroetter Syndrome in a Young Female.

Authors:  Vikram Sangani; Mytri Pokal; Mamtha Balla; Vijay Gayam; Venu Madhav Konala
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

8.  Post-thrombotic syndrome after upper extremity deep vein thrombosis: An international Delphi consensus study.

Authors:  Robert J C M F de Kleijn; Ludo Schropp; Eline S van Hattum; Çagdas Ünlu; Saskia Middeldorp; Mathilde Nijkeuter; Jan Westerink; Bart-Jeroen Petri; Gert J de Borst
Journal:  J Thromb Haemost       Date:  2022-06-20       Impact factor: 16.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.